
|Articles|July 2, 2014
- Pharmaceutical Technology-07-02-2014
- Volume 38
- Issue 7
Environmental Monitoring System Improves Efficiency
Author(s)Melanie Sena
Environmental Monitoring System Improves Efficiency
The Growth Direct System from Rapid Micro Biosystems i s designed to automate the incubation, detection, enumeration, and reporting steps for environmental monitoring and bioburden applications in pharmaceutical quality control laboratories. The technology is based on the detection of the natural auto-fluorescence of microorganisms, which requires no additional reagents to detect growing colonies. According to the company, the system can be located near manufacturing facilites, which increases efficiency and reduces the travel risk with samples.
Articles in this issue
over 12 years ago
Trends in Manufacturing and Equipmentover 12 years ago
The Mainstreaming of Continuous Flow API Synthesisover 12 years ago
Health Systems Raise the Bar on Reimbursing New Drugsover 12 years ago
Data Integrityover 12 years ago
Automating Online Sampling of Bioprocessesover 12 years ago
Sieve Shakers Ensure Reliabilityover 12 years ago
Laboratory Filter-Dryer Enables Scalabilityover 12 years ago
Sterilization of Blow-Fill-Seal Equipment for Aseptic FillingRelated to this article

How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.

Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.

PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.

Nate Edwards of Arya Consulting, Elisabeth Gardiner of Tevard Biosciences, and Donny Xu of the RTW Institute discuss global competition for rare disease therapies.

Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.

Marco Pupo, PhD, innovation and development coordinator at Anemocyte, explains how capping is measured for mRNA synthesis and how upstream process design shapes downstream purity.
Trending on Pharmaceutical Technology
1
Challenges in Oral Delivery of Peptides: Bioavailability
2
AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis
3
Neladalkib Accelerated Approval: What ALK Drug Developers Should Know
4
Manufacturing Intelligence: Where Pharma Should Slow AI
5



